Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. It covers many disciplines and spans molecules (e.g. molecular biology, biochemistry) through systems (e.g. neurophysiology) to behaviour (e.g. cognition, psychopharmacology). The journal covers all aspects of neuroscience with an emphasis on neurotransmitters and their receptors, ion channels, signalling, psychopharmacology and animal models of disease, such as investigations on the neurobiology of cognition, depression, schizophrenia, anxiety, epilepsy, ischemia, neuroprotection, neurodegeneration, drugs of abuse and pain.
For more information, please visit: www.journals.elsevier.com/neuropharmacology